Regulation vs. Innovation in AI: Friend or Foe?
summary
Europe commits to a risk-management approach through an AI Act with enforcement and sanctions, plus a proposed AI Office that can order developers to fix dangerous models and an independent scientific board to advise regulators. Public investment includes €8 billion supercomputing network with free startup access. Concrete aims: third‑party verification of medical and skin‑cancer claims, national cancer imaging databases, weather models moving from ~25 km resolution toward 1 km (or 300 m), and strict limits on biometric surveillance and predictive policing.
AI-written summary · about
chapters (9)
- 0:00Europe’s AI stance
- 2:20Regulation vs. innovation
- 4:37Risk management approach
- 7:30Regulating generative AI
- 10:09Freedom with AI regulation
- 12:37Public investment in AI
- 16:38Supercomputing for AI startups
- 18:05Europe’s steps and outlook
- 20:27Q&A
related talks
01h 11mThe Intersection of AI and Regulation How Organisations and Regulators Should...
24m2025: year of Ai dilemma - ethics, regulations and innovations
25mExpert Insights | Keynote
31mCompliance in the Age of AI
01h 12mOut of Alignment Conflicting Trends in the Governance of Advanced Artificial ..
15mEthical and Legal AI Compliance in the Age of FOSS
12mBuilding trust in AI: Insights from MDIA at AIBC Euro-Med
01h 00mAI: Law, Policy, and Common Sense Suggestions to Stay Out of Trouble